# Efficacy and Safety of AEYE Diagnostic Screening (AEYE-DS) Software Device for Detection of Diabetic Retinopathy From Digital Funduscopic Images

> **NCT06241664** · NA · COMPLETED · sponsor: **AEYE Health Inc** · enrollment: 601 (actual)

## Conditions studied

- Diabetic Retinopathy, DR
- Diabetic Mellitus

## Interventions

- **DEVICE:** AEYE-DS Software

## Key facts

- **NCT ID:** NCT06241664
- **Lead sponsor:** AEYE Health Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-31
- **Primary completion:** 2024-10-02
- **Final completion:** 2025-02-20
- **Target enrollment:** 601 (ACTUAL)
- **Last updated:** 2025-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06241664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06241664, "Efficacy and Safety of AEYE Diagnostic Screening (AEYE-DS) Software Device for Detection of Diabetic Retinopathy From Digital Funduscopic Images". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06241664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*